The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

Wed, 11th Oct 2023 08:51

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

The FTSE 100 index opened up 10.29 points, or 0.1%, at 7,638.50. The FTSE 250 was down 17.23 points, or 0.1%, at 17,950.44. The AIM All-Share was up 1.54 points, or 0.2%, at 699.63.

The Cboe UK 100 was up 0.1% at 762.70, the Cboe UK 250 was flat at 15,641.48, and the Cboe Small Companies was flat at 13,264.70.

"The surge of optimism, fuelled by hopes the [US Federal Reserve] will go easier with its interest rate policies and buoyed by expectations of fresh stimulus in China, appears to have plateaued. A little more caution is returning, as investors look ahead to tomorrow's snapshot of inflation in the United States," said Susannah Streeter, head of money and markets at Hargreaves Lansdown.

The latest US consumer price inflation print will be published at 1330 BST on Thursday.

According to FXStreet-cited consensus, markets are expecting consumer price inflation to cool to 3.6% on an annual basis in September, from 3.7% in August. Core inflation - which includes items such as energy and food - is expected to pull back to 4.1% from 4.3%.

On Tuesday, a senior official on the US central bank's rate-setting committee said the Fed is on track to tackle inflation without pushing the country into a damaging recession.

"We feel like we're on track for a soft landing," Minneapolis Fed President Neel Kashkari told a conference in North Dakota, using a popular term to describe tackling inflation while avoiding a recession.

"Inflation has come down quite a bit, the labor market has remained strong, maybe we can get inflation all the way back down and avoiding (sic) a deep recession," he said.

His words added to a doveish chorus from Fed officials in recent days.

On Monday, two senior Fed officials said that the US central bank should be careful when deciding whether or not to hike interest rates further to bring down inflation.

Fed Vice Chair Philip Jefferson said the central bank needed to "proceed carefully" with forthcoming interest rate decisions, while Dallas Fed President Lorie Logan said she would "carefully" evaluate economic and financial developments when deciding whether to back another rate hike.

Their doveish rhetoric has lifted hope that interest rates in the world's largest economy may finally be hitting their peak. However, a higher than expected inflation print could throw cold water on these expectations.

In London, GSK was one of the top blue-chip performers in early morning trade, up 1.2% after it announced it has reached a confidential settlement in the Cantlay/Harper case filed in California state court.

The litigation related to its heartburn medication Zantac, also known as ranitidine. Zantac is the subject of numerous lawsuits, which allegedly link the drug with cancer.

The case, which was set to begin trial on November 13, will now be dismissed.

The company added it has also settled the three remaining breast cancer bellwether cases in California.

The pharmaceutical company said the settlements reflect its desire to "avoid the distraction related to protracted litigation" and does not admit any liability in the settlements.

In the FTSE 250, Travis Perkins was the worst performing stock, down 10% after the builders merchant warned that falling prices of commodity products have hurt gross profit and narrowed its profit margins, leading it to cut earnings guidance.

Travis guided for 2023 adjusted operating profit of GBP175 million to GBP195 million. This is down from its previous guidance of GBP240 million, provided in August at the time of its interim results. It also will be down at least 34% from GBP295 million in 2022.

PageGroup also suffered on Wednesday morning, tumbling 3.6% after it warned of short-term uncertainty in the recruitment sector.

"Candidate shortages remain acute and are supportive of continued high fee rates. Salary levels remain elevated, albeit the salary increases offered to candidates reduced compared to [the third quarter of 2023]. These lower offers, combined with lower candidate confidence, led to a further increase in the number of offers rejected by candidates, either through employer buybacks or unwillingness to risk the move for the size of incentive on offer," the recruitment firm said.

As a result, PageGroup said it expects to deliver operating profit between GBP125 million and GBP130 million in 2023. In 2022, it delivered an operating profit of GBP196.1 million.

Elsewhere in London, Forettra dropped 5.9% as it lamented that the signs of market improvement seen in May and June did not continue into the second half of the year.

In July, the company guided for full-year earnings before interest, tax, depreciation and amortization with a more balanced split between the first and second half. However, Forterra said it now expecting demand demand to remain at the level it has experienced over the past quarter and, consequently, now expect full-year Ebitda to be below its previous expectations.

In European equities on Wednesday, the CAC 40 in Paris was down 0.8%, while the DAX 40 in Frankfurt was down 0.2%.

In Tokyo on Wednesday, the Nikkei 225 index closed up 0.6%. The S&P/ASX 200 in Sydney closed up 0.7%. In China, the Shanghai Composite closed up 0.1%, while the Hang Seng index in Hong Kong was up 1.4%.

Wall Street ended higher on Tuesday, with the Dow Jones Industrial Average up 0.4%, the S&P 500 up 0.5% and the Nasdaq Composite up 0.6%.

The pound was quoted at USD1.2281 at early on Wednesday in London, up from USD1.2270 at the London equities close on Tuesday. The euro stood at USD1.0607, virtually unchanged against USD1.0606. Against the yen, the dollar was trading at JPY148.84, higher compared to JPY148.74.

Brent oil was quoted at USD87.91 a barrel early Wednesday in London, up from USD87.50 at the London equities close on Tuesday. Gold was quoted at USD1,864.94 an ounce, higher against USD1,859.73.

Still to come on Wednesday's economic calendar, a US producer price index reading will be released at 1330 BST. The US Federal Reserve's September meeting minutes will be published at 1900 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.